What Can Cause Someone’s Knee to Lock Up?

Translate to Spanish or other 102 languages!

Locked knee occurs when a person cannot bend or straighten their knee. Causes include injury to the area and inflammation of the joint. Image for illustration puposes
Locked knee occurs when a person cannot bend or straighten their knee. Causes include injury to the area and inflammation of the joint. Image for illustration puposes
- Advertisement -

The knees are two of the most important joints in the body. Aside from supporting a person’s body weight, the knees enable everyday activities, such as standing up, walking, and climbing stairs.

Due to such frequent use, the knees are prone to injury and degeneration, both of which can lead to locked knees. 

There are two types of locked knee: pseudo and true locked knee. Keep reading for more information about their causes, symptoms, and treatments.

- Advertisement -

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/326877?slot_pos=article_2&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-02-21&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Behavioral’s Summer Mental Health Tips for Kids

STHS Behavioral urges families to prioritize emotional well-being by maintaining routines, encouraging social connections and fostering growth beyond the classroom.

New Insight Into the Iron-Retention Strategies of Colorectal Cancer Cells

Mega Doctor News by Michigan Medicine - University of Michigan Newswise — ANN ARBOR, Michigan...

Study: Weight Loss Drugs Cut Risk of Four Cancers by Half or More

Medical News Today The use of glucagon-like peptide-1 (GLP-1) receptor agonistTrusted Source medications continues...

FDA Approves Expanded Use of Kidney Cancer Treatment Rooted in UTSW Discovery

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug. This move marks the latest expansion of belzutifan’s indications after it was originally approved in 2021.
- Advertisement -